Intravital optical imaging for immune cell tracking after photoimmunotherapy with plasmonic gold nanostars

Ericka Chorniak1, Yang Liu2,3,4, Ren Odion2,4

  • 1Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, United States of America.

Nanotechnology
|August 12, 2022
PubMed

Insights

This study introduces a novel photoimmunotherapy combining gold nanostars and checkpoint inhibitors for bladder cancer. This combined treatment effectively triggers anti-cancer immune responses and reduces tumors in animal models.

Area of Science:

  • Oncology
  • Nanomedicine
  • Immunotherapy

Background:

  • Bladder cancer is a common malignancy, with many diagnoses at late or metastatic stages.
  • Current treatments for advanced bladder cancer have limitations.

Purpose of the Study:

  • To develop and evaluate a novel photoimmunotherapy for bladder cancer.
  • To investigate the underlying immune mechanisms of this novel treatment using advanced imaging techniques.

Main Methods:

  • Combination therapy using gold nanostar-mediated photothermal therapy and checkpoint inhibitor immunotherapy.
  • Murine animal models for bladder cancer treatment efficacy studies.
  • Intravital optical imaging with dorsal skinfold window chamber models to track immune cell dynamics.

Main Results:

  • The developed photoimmunotherapy demonstrated superior efficacy compared to individual treatments in a murine model.
  • Photoimmunotherapy successfully triggered systemic anti-cancer immune responses.
  • Immune cell accumulation in distant metastatic tumors was observed following treatment.

Conclusions:

  • Combined photothermal therapy and immunotherapy represent a promising strategy for bladder cancer treatment.
  • Intravital optical imaging is a valuable tool for studying cancer immunotherapy mechanisms.
  • This approach has the potential to enhance immune cell infiltration and anti-tumor activity in metastatic settings.